179 related articles for article (PubMed ID: 2144431)
61. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
62. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
63. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome.
Gaither TA; Gallin JI; Iida K; Nussenzweig V; Frank MM
Inflammation; 1984 Dec; 8(4):429-44. PubMed ID: 6240460
[TBL] [Abstract][Full Text] [Related]
64. Erythrocyte complement receptors.
Birmingham DJ
Crit Rev Immunol; 1995; 15(2):133-54. PubMed ID: 8573285
[TBL] [Abstract][Full Text] [Related]
65. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
Rasmussen JM; Jepsen HH; Svehag SE
Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
[TBL] [Abstract][Full Text] [Related]
66. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
[TBL] [Abstract][Full Text] [Related]
67. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).
Csípö I; Kiss E; Soltész P; Antal-Szalmás P; Szegedi G; Cohen JH; Taylor RP; Kávai M
Clin Exp Immunol; 1999 Dec; 118(3):458-64. PubMed ID: 10594568
[TBL] [Abstract][Full Text] [Related]
68. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
69. Interaction of complement-solubilized immune complexes (IC) with CR1 receptors on human erythrocytes. Polysulfated compounds inhibit IC binding and induce IC-release from CR1.
Jepsen HH; Ekre HP; Svehag SE
Int J Immunopharmacol; 1987; 9(5):587-95. PubMed ID: 2442111
[TBL] [Abstract][Full Text] [Related]
70. Human erythrocytes inhibit complement-mediated solubilization of immune complexes.
Dorval BL; Cosio FG; Birmingham DJ; Hebert LA
J Immunol; 1989 Apr; 142(8):2721-7. PubMed ID: 2522967
[TBL] [Abstract][Full Text] [Related]
71. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).
Marquart HV; Svendsen A; Rasmussen JM; Nielsen CH; Junker P; Svehag SE; Leslie RG
Clin Exp Immunol; 1995 Jul; 101(1):60-5. PubMed ID: 7621593
[TBL] [Abstract][Full Text] [Related]
72. Relationships between C3b receptor (CR1) activity of erythrocytes and positive Coombs' tests.
Inada Y; Kamiyama M; Kanemitsu T; Clark WS; Asai Y
Ann Rheum Dis; 1986 May; 45(5):367-72. PubMed ID: 2940981
[TBL] [Abstract][Full Text] [Related]
73. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
[TBL] [Abstract][Full Text] [Related]
74. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
[TBL] [Abstract][Full Text] [Related]
75. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
[TBL] [Abstract][Full Text] [Related]
76. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
[TBL] [Abstract][Full Text] [Related]
77. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
[TBL] [Abstract][Full Text] [Related]
78. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
Fyfe A; Holme ER; Zoma A; Whaley K
Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
[TBL] [Abstract][Full Text] [Related]
79. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
80. Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis.
Coppo R; Amore A; Roccatello D; Amoroso A; Maffei S; Quattrocchio G; Molino A; Gianoglio B; Piccoli G
Nephrol Dial Transplant; 1989; 4(11):932-8. PubMed ID: 2516882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
